Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell × Magnetic Resonance Spectroscopy × Clear all

NCT07225985 2026-05-11

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell